Useful Links
Competitive Intelligence in Pharma Conference
27-28 January 2009, Madrid, Spain
The pharmaceutical and biotech market is changing. As product pipelines decrease, the threat of competition intensifies. Add to this the increase in generic and biosimilar entry and spiralling operation costs it’s easy to see that enough emphasis can not be placed on the importance of competitive intelligence (CI) to ensure the safety of current pipelines, increase market share and enhance company growth.
Following on the success of our 11th Competitive Intelligence in Pharma conference, which saw the largest European gathering of Competitive Intelligence professionals from the pharma and biotech industry, VIBpharma is proud to announce the 12th Annual Competitive Intelligence in Pharma conference will take place on 27-28 January 2009 in Madrid, Spain.
Extensive research at VIBpharma has ensured that that this conference programme accurately reflects the key priorities, challenges and desired solutions, as identified by experts from the pharmaceuticals industry.
Through a series of presentations and interactive discussions, covering issues such as anticipating brand erosion by generics, measuring the internal performance and ROI, integrating CI with other strategic functions, communicating CI to senior executives and creating a global intelligence network, participants will gain new insight and share hands-on experiences with leading companies in the pharma industry who have learnt to use Competitive Intelligence effectively and profitably
Contact us: events@vibevents.com
Full Details
BioBusiness 2009
16-18 February 2009, President Wilson Hotel, Geneva
Fuelling Growth: Identifying High-Value Partners And Establishing Innovative Deal Structures
As the global Bio partnering calendar becomes more and more complicated and good deals become harder to find, BioBusiness stands out as the only event which has maintained credibility and quality throughout its 6-year history. Senior BioBusiness delegates attended the conference for 3 days of intensive networking, learning and deal-making. They gained unique insight into some of the hottest deals, including Genzyme/AnorMED and AstraZeneca/BMS as well as making invaluable contacts through one-to-ones and designated informal networking.
Register via 3 simple ways:
• Online at http://www.wbr.co.uk/BioBusiness/?cm_mmc=UK%20Affiliate-_-UK%20Listing-_-10978.003-_-PharmaWire
• Call us on +44 (0) 207 368 9465
• Email us at info@wbr.co.uk
Full Details
Life Sciences Mergers & Acquisitions
11-12 March 2009, New York
With the survival of both pharmaceutical and biotech companies often dependant on strategic and successful M&A deals, there is no room for error in mastering the nuances of today’s complex transactions. In response, ACI has developed the 3rd Annual Life Sciences Mergers and Acquisitions conference featuring a faculty of in-house legal and business development professionals who consistently face and succeed in solving the challenges inherent in these deals, including:
- Knowing how the current credit crisis stands to change life sciences deals
- Conducting thorough due diligence that encompasses all areas of review: commercial, scientific, financial and IP
- Employing best practices for compliance with regulatory guidelines to ensure the value of your product
- Overcoming the specific challenges that may arise when entering into a deal with a foreign company
- Setting expectations and creating momentum throughout the transition
Full Details
Windhover's 4th Annual FDA/CMS Summit
4-5 December 2008, Grand Westin Hotel, Washington, DC
FDA/CMS Summit is t
he only event that offers face-to-face dialogue with policy makers and top industry executives on how the new government will drive pre- and post-regulatory approval and commercialization strategies. This is the first event after the 2008 election, where executives can find out from top decision-makers and insiders how the Obama administration will impact the biopharma industry. Get a first-hand perspective on everything from user fees to health care fraud prosecutions, to pharma marketing and promotions regulation and enforcement, Medicaid and Medicare reimbursement and even pricing strategies. To register, contact Pat Cardone, (203) 838-4401 ext. 124, or p.cardone@elsevier.com.
Full Details